![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/00 | (2006.01) |
A61K 38/00 | (2013.01) | ||
C12N 15/113 | (2010.01) | ||
C12N 15/1138 | (2013.01) | ||
A61P 29/00 | (2006.01) | ||
A61P 29/00 | (2018.01) | ||
C12N2310/11 | (2013.01) |
(11) | Number of the document | 3565571 |
(13) | Kind of document | T |
(96) | European patent application number | 18702408.8 |
Date of filing the European patent application | 2018-01-08 | |
(97) | Date of publication of the European application | 2019-11-13 |
(45) | Date of publication and mention of the grant of the patent | 2022-03-23 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2018/050336 |
Date | 2018-01-08 |
(87) | Number | WO 2018/127582 |
Date | 2018-07-12 |
(30) | Number | Date | Country code |
201700257 | 2017-01-06 | GB |
(72) |
WATERWORTH, Toby , GB
JOHNSON, Lorin , GB
THOMAS, Janette , GB
WEBB, Michael , GB
|
(73) |
Atlantic Pharmaceuticals (Holdings) Ltd ,
Atlantic House, 12 Rose & Crown Walk, Saffron Walden, Essex CB10 1JH,
GB
|
(54) | ALICAFORSEN FORMULATIONS |
ALICAFORSEN FORMULATIONS |